Home/Filings/4/0000899243-22-029649
4//SEC Filing

Hearne Michael S 4

Accession 0000899243-22-029649

CIK 0000920465other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 8:17 PM ET

Size

73.6 KB

Accession

0000899243-22-029649

Insider Transaction Report

Form 4
Period: 2022-08-22
Hearne Michael S
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-2252,1910 total
    Exercise: $4.53Common Stock (52,191 underlying)
  • Disposition from Tender

    Common Stock

    2022-08-22$6.23/sh9,607,934$59,857,4290 total(indirect: BY LP)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221390 total
    Exercise: $5.24Common Stock (139 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221470 total
    Exercise: $4.50Common Stock (147 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221,6480 total
    Exercise: $3.88Common Stock (1,648 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-22100,0000 total
    Exercise: $4.55Common Stock (100,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221080 total
    Exercise: $6.71Common Stock (108 underlying)
  • Disposition to Issuer

    Common Stock

    2022-08-22$6.23/sh10,186$63,4590 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221340 total
    Exercise: $4.97Common Stock (134 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-2278,5520 total
    Exercise: $4.81Common Stock (78,552 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221690 total
    Exercise: $3.91Common Stock (169 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221410 total
    Exercise: $4.68Common Stock (141 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221360 total
    Exercise: $5.35Common Stock (136 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221960 total
    Exercise: $3.40Common Stock (196 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221180 total
    Exercise: $6.12Common Stock (118 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221270 total
    Exercise: $5.71Common Stock (127 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221730 total
    Exercise: $4.18Common Stock (173 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221720 total
    Exercise: $4.24Common Stock (172 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221690 total
    Exercise: $4.30Common Stock (169 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221640 total
    Exercise: $4.44Common Stock (164 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-222010 total
    Exercise: $3.61Common Stock (201 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-223860 total
    Exercise: $3.76Common Stock (386 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221480 total
    Exercise: $4.90Common Stock (148 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221700 total
    Exercise: $4.28Common Stock (170 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-227280 total
    Exercise: $3.99Common Stock (728 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221810 total
    Exercise: $4.02Common Stock (181 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221860 total
    Exercise: $3.90Common Stock (186 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-223730 total
    Exercise: $3.96Common Stock (373 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-225580 total
    Exercise: $4.01Common Stock (558 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221570 total
    Exercise: $4.61Common Stock (157 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221730 total
    Exercise: $4.21Common Stock (173 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-221480 total
    Exercise: $4.92Common Stock (148 underlying)
Footnotes (3)
  • [F1]This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 10, 2022, by and among the Issuer, Innoviva, Inc., a Delaware corporation ("Parent"), and Innoviva Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Parent ("Purchaser"), to which Purchaser completed a tender offer for shares of common stock of the Issuer, $0.0001 par value per share (each, a "Share"), and thereafter merged with and into the Issuer (the "Merger") effective as of August 22, 2022 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $6.23 per Share, in cash, without interest (the "Offer Price") and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.
  • [F2]The Shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Tang Capital Management, LLC ("TCM") is the general partner of TCP. Michael Hearne is the Chief Financial Officer of La Jolla Pharmaceutical Company, as well as the Chief Financial Officer of TCM. Mr. Hearne has a pecuniary interest in the shares beneficially held by TCP.
  • [F3]Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an "Issuer Stock Option") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Offer Price over the exercise price payable per Share with respect to such Issuer Stock Option.

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeother

Related Parties

1
  • filerCIK 0001759910

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 8:17 PM ET
Size
73.6 KB